Publications by authors named "J Abeykoon"

Claim this Profile
C
Cyclin D1 Overexpression With Cytoplasmic Localization Distinguishes Erdheim-Chester Disease From Reactive Histiocytic Infiltrates.
Alma R Oskarsdottir, Aishwarya Ravindran, Matthew J Koster, Jithma P Abeykoon, Nora N Bennani

Am J Surg Pathol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
POD24 is a Novel Determinant of Prognosis in Patients with Waldenström Macroglobulinemia.
Saurabh Zanwar, Jithma P Abeykoon, Shirley D'Sa, Damien Roos-Weil, Dirk R Larson

Blood Adv· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics analysis reveals a unique epigenetic signature in MYD88 wild-type Waldenstrom macroglobulinemia.
Karan Chohan, Jonas Paludo, Surendra Dasari, Joseph P Novak, Jithma P Abeykoon

Haematologica· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histiocyte Society blueprint for non-Langerhans cell histiocytosis research: unraveling complex diseases through collaboration.
Oshrat Hershkovitz-Rokah, Jithma P Abeykoon, Aishwarya Ravindran, Gaurav Goyal

Haematologica· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma.
Matthew J Rees, Timothy T Xu, Suheil Albert Atallah-Yunes, Kenneth J C Lim, Sikander Ailawadhi, Jithma P Abeykoon

Clin Lymphoma Myeloma Leuk· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis